Androgens and depression: A review and update

Kevin T. Nead

doi:10.1097/MED.0000000000000477

Androgens and depression: A review and update

Kevin T. Nead

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Purpose of review: The aim of this study is to summarize recently published literature examining androgens and depression.Recent findingsThe impact of androgen levels, androgen replacement therapy and pharmacologic androgen deprivation on depression and depressive symptoms remain active areas of investigation. Recent publications support the finding that testosterone replacement therapy in men with low testosterone may improve depression, and that androgen deprivation therapy in men with prostate cancer may contribute to depression.SummaryWe review the recent literature on androgens and depression and highlight key developments.

Original language	English (US)
Pages (from-to)	175-179
Number of pages	5
Journal	Current Opinion in Endocrinology, Diabetes and Obesity
Volume	26
Issue number	3
DOIs	https://doi.org/10.1097/MED.0000000000000477
State	Published - Jun 1 2019
Externally published	Yes

Keywords

androgen
depression
prostate cancer
testosterone

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology
Nutrition and Dietetics

Access to Document

10.1097/MED.0000000000000477

Cite this

@article{a11e76a1f56e4e768f5e66583507e581,

title = "Androgens and depression: A review and update",

abstract = "Purpose of review: The aim of this study is to summarize recently published literature examining androgens and depression.Recent findingsThe impact of androgen levels, androgen replacement therapy and pharmacologic androgen deprivation on depression and depressive symptoms remain active areas of investigation. Recent publications support the finding that testosterone replacement therapy in men with low testosterone may improve depression, and that androgen deprivation therapy in men with prostate cancer may contribute to depression.SummaryWe review the recent literature on androgens and depression and highlight key developments.",

keywords = "androgen, depression, prostate cancer, testosterone",

author = "Nead, {Kevin T.}",

note = "Funding Information: Dr. Nead is supported through a Gerber Foundation Novice Research Grant and by the Marlene Shlomchik Fellowship in Cancer Research through the Abramson Cancer Center. Publisher Copyright: {\textcopyright} 2019 Wolters Kluwer Health, Inc.",

year = "2019",

month = jun,

day = "1",

doi = "10.1097/MED.0000000000000477",

language = "English (US)",

volume = "26",

pages = "175--179",

journal = "Current Opinion in Endocrinology, Diabetes and Obesity",

issn = "1752-296X",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Androgens and depression

T2 - A review and update

AU - Nead, Kevin T.

N1 - Funding Information: Dr. Nead is supported through a Gerber Foundation Novice Research Grant and by the Marlene Shlomchik Fellowship in Cancer Research through the Abramson Cancer Center. Publisher Copyright: © 2019 Wolters Kluwer Health, Inc.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Purpose of review: The aim of this study is to summarize recently published literature examining androgens and depression.Recent findingsThe impact of androgen levels, androgen replacement therapy and pharmacologic androgen deprivation on depression and depressive symptoms remain active areas of investigation. Recent publications support the finding that testosterone replacement therapy in men with low testosterone may improve depression, and that androgen deprivation therapy in men with prostate cancer may contribute to depression.SummaryWe review the recent literature on androgens and depression and highlight key developments.

AB - Purpose of review: The aim of this study is to summarize recently published literature examining androgens and depression.Recent findingsThe impact of androgen levels, androgen replacement therapy and pharmacologic androgen deprivation on depression and depressive symptoms remain active areas of investigation. Recent publications support the finding that testosterone replacement therapy in men with low testosterone may improve depression, and that androgen deprivation therapy in men with prostate cancer may contribute to depression.SummaryWe review the recent literature on androgens and depression and highlight key developments.

KW - androgen

KW - depression

KW - prostate cancer

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=85065510059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065510059&partnerID=8YFLogxK

U2 - 10.1097/MED.0000000000000477

DO - 10.1097/MED.0000000000000477

M3 - Review article

C2 - 30958398

AN - SCOPUS:85065510059

SN - 1752-296X

VL - 26

SP - 175

EP - 179

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

IS - 3

ER -

Androgens and depression: A review and update

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this